drugset / Trial / NCT01429077

Augmenting Language Therapy for Aphasia: Levodopa

NCT01429077

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the effectiveness of the medication levodopa, in combination with speech-language treatment, on the language outcome of study subjects with nonfluent aphasia (i.e. difficulty with the comprehension and expression of spoken and written language) following a stroke.

Timeline

Start
2007-10
Primary completion
2012-03
Completion
2012-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Carbidopa Unknown 25 mg Oral
Comparator Levodopa Small molecule 100 mg Oral

Indications